Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemolytic Disease of the Newborn”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06580067
What this trial is testing

The Feasibility of the Pray Until Something Happens (PUSH) Intervention-OUTPATIENT

Who this might be right for
Sickle Cell DiseaseStressPain
University of Florida 40
Post-approval studies (Phase 4)Study completedNCT00105495
What this trial is testing

Efficacy Study in Removing Excess Iron From the Heart

Who this might be right for
Thalassemia MajorHemosiderosis
ApoPharma 60
Not applicableLooking for participantsNCT06071377
What this trial is testing

Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)

Who this might be right for
Sickle Cell Trait
National Alliance for Sickle Cell Centers 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT06399107
What this trial is testing

Investigation Into the Use of BAH243 Lentiviral Vector for Gene Therapy in Treating Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseSickle-Cell Disease With Crisis
Essen Biotech 85
Testing effectiveness (Phase 2)Study completedNCT00434473
What this trial is testing

IMPACTS Trial: Investigation of the Modulation of Phospholipase in Acute Chest Syndrome

Who this might be right for
Sickle Cell DiseaseVaso-occlusive CrisisAcute Chest Syndrome
Anthera Pharmaceuticals 30
Large-scale testing (Phase 3)Ended earlyNCT03820466
What this trial is testing

Effect of Platelet Inhibition and / or Lipid Lowering in Non-ACS-patients With Positive Troponin

Who this might be right for
Acute Chest Syndrome
Dr. med. Mahir Karakas 68
Not applicableUnknownNCT05303506
What this trial is testing

Study on the Effect of Different Risk Factors on the Growth Parameters of Thalassemic Patients in Assiut (AUCH)

Who this might be right for
Thalassemia Major
Assiut University 50
Not applicableStudy completedNCT00006138
What this trial is testing

Diagnostic Pilot Study of Dual Energy Absorptiometry in the Detection of Osteopenia or Osteoporosis in Patients With Thalassemia Major

Who this might be right for
OsteoporosisThalassemia MajorOsteopenia
National Center for Research Resources (NCRR) 35
Not applicableNot Yet RecruitingNCT06769139
What this trial is testing

Evaluation of the Impact of Red Blood Cell Exchange on Thrombo-inflammation in Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
University Hospital, Toulouse 20
Post-approval studies (Phase 4)Study completedNCT04400487
What this trial is testing

Actigraphy Improvement With Voxelotor (ActIVe) Study

Who this might be right for
Sickle Cell DiseaseSickle Cell Anemia
Pfizer 25
Post-approval studies (Phase 4)Study completedNCT04662931
What this trial is testing

An Indian Multi-centric Phase IV Study to Assess the Safety of Crizanlizumab in Sickle Cell Disease Patients

Who this might be right for
Sickle Cell Disease (SCD)
Novartis Pharmaceuticals 140
Early research (Phase 1)Not Yet RecruitingNCT07799571
What this trial is testing

Buprenorphine for the Management of Pain in Children With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease (SCD)Sickle Cell Disease Vaso-occlusive CrisisSickle Cell Anemia Crisis+4 more
Natasha Archer 25
Not applicableUnknownNCT04918056
What this trial is testing

Genetic Variants Affecting the Clinical Severity of Beta Thalassemia

Who this might be right for
Beta Thalassemia
Nanfang Hospital, Southern Medical University 1,300
Not applicableUnknownNCT06158945
What this trial is testing

The Role of Endothelin 1 as a Marker of Renal Impairment in Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Sohag University 30
Early research (Phase 1)Study completedNCT06291961
What this trial is testing

A Safety and Efficacy Study Evaluating CS-101 in Subjects With β-Thalassemia Major

Who this might be right for
Beta-Thalassemia Major
CorrectSequence Therapeutics Co., Ltd 9
Large-scale testing (Phase 3)Study completedNCT02187003
What this trial is testing

Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease

Who this might be right for
Anemia, Sickle Cell
Biossil Inc. 345
Post-approval studies (Phase 4)UnknownNCT05462548
What this trial is testing

The Safety and Efficiency of Luspatercept in Chinese Adults With Transfusion Dependent β-thalassemia: a Real-world Study

Who this might be right for
Thalassemia MajorTransfusion-dependent Anemia
Sun Yat-sen University 20
Large-scale testing (Phase 3)Looking for participantsNCT05912517
What this trial is testing

Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)

Who this might be right for
Hemolytic Disease of the Fetus and Newborn
Janssen Research & Development, LLC 120
Not applicableStudy completedNCT03653676
What this trial is testing

Sickle Cell Pro-Inflammatory Response to Interval Training Study

Who this might be right for
Sickle Cell Disease
Ann & Robert H Lurie Children's Hospital of Chicago 110
Post-approval studies (Phase 4)UnknownNCT02594904
What this trial is testing

Efficacy of Yinzhihuang Oral Liquid on Indirect Bilirubin of Neonates With Glucose-6-phosphate Dehydrogenase Deficiency

Who this might be right for
Neonatal Hyperbilirubinemia
Southern Medical University, China 300
Next Page